norm: drugs made in america acquisitionNAICS 525910 · USno LEI · CIK 0002028614Max severity: Low

Canonical registry

Drugs Made In America Acquisition Corp.

ent_019e3eaa58769853fd483f2c4d578728

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: Drugs Made In America Acquisition Corp.
Normalized: drugs made in america acquisition— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: No match
SEC EDGAR CIK: 0002028614
Domain: None on record

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2026-04-15
Special purpose acquisition company (SPAC) Item 1C disclosure stating it has no business operations beyond identifying acquisition candidates, does not face significant cybersecurity risk, has not adopted a formal cybersecurity risk management program, and has not encountered any cybersecurity incidents since its IPO. Board of directors holds general oversight responsibility.